Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.

E. T. Creagan, D. L. Ahmann, A. J. Schutt, D. J. Schaid

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)769-770
Number of pages2
JournalCancer Treatment Reports
Issue number7-8
StatePublished - Jul 1987

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this